Search

Principal Scientist, Toxicology

BioPhase Solutions
locationSan Diego, CA, USA
PublishedPublished: 6/14/2022
Science
Full Time

Job Description

Job DescriptionPrincipal Scientist, Preclinical Toxicology
Location: San Diego, CA | Full-time
Summary
We are seeking a senior-level toxicologist to lead and oversee GLP-compliant preclinical toxicology programs supporting IND, NDA, and BLA submissions. This role is ideal for a highly experienced Study Director with strong regulatory expertise and the ability to balance CRO service delivery with sponsor-driven drug development goals.
Responsibilities

  • Serve as Study Director for GLP in vivo and in vitro toxicology studies
  • Design, oversee, and interpret toxicology studies aligned with FDA, ICH, and international regulatory expectations
  • Act as the primary scientific and client-facing lead for preclinical toxicology programs
  • Integrate toxicology, pathology, and clinical pathology data into defensible regulatory conclusions
  • Author, review, and approve final study reports and nonclinical regulatory content
  • Support IND, NDA, and BLA submissions and participate in FDA-facing interactions as needed
  • Ensure GLP compliance and represent the organization during audits and inspections
  • Coordinate cross-functionally to ensure timelines, data integrity, and scientific rigor


Qualifications

  • PhD in Toxicology, Pharmacology, or related discipline
  • 5–7+ years of experience directing GLP toxicology studies, preferably in a CRO environment
  • Proven track record as Study Director on completed GLP studies supporting regulatory submissions
  • Direct experience contributing to IND/NDA/BLA nonclinical packages
  • Strong understanding of FDA expectations and regulatory strategy
  • DABT certification strongly preferred


Why Join

  • Senior scientific leadership role with high impact on drug development programs
  • Opportunity to guide complex preclinical toxicology strategies
  • Collaborative, science-driven environment supporting innovative therapeutics
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...